C-TASC President Wins International Clinical Research Award

C-TASC President Wins International Clinical Research Award

Baltimore, Md. - April 28, 2010 - Clinical Trials & Surveys Corp. (C-TASC), a clinical trials solutions company, announced today that its president, Dr. Bruce Thompson, has been awarded the 2010 Innovation in Clinical Research Award from the Association of Clinical Research Professionals (ACRP). Dr. Thompson was recognized Monday, April 26 at the ACRP 2010 Global Conference & Exhibition in Tampa, Florida. ACRP is a global association comprised of more than 20,000 individuals in over 60 countries dedicated to clinical research and development.

The Innovation in Clinical Research Award recognizes an individual who has demonstrated creativity and innovation in adapting or implementing new or improved processes into a clinical trial function. Dr. Thompson, who has specialized in supporting best practices management of clinical trials for government, university and private organizations for more than 20 years as head of C-TASC, was honored for C-TASC's development and implementation of a Web-based software system that manages clinical trial data more efficiently and cost-effectively.

Since implementing the technology, called StudyCTMS, C-TASC has grown from a $5 million operation in 2008 to a projected $10 million operation in 2010 and will nearly double its staff from 35 employees to 60. In the future, C-TASC plans to release StudyCTMS as an off-the-shelf product that will enable small- and medium-sized researchers to affordably conduct clinical trials in a manner consistent with FDA standards.

"ACRP is pleased to recognize Dr. Thompson with its Innovation in Clinical Research Award, as he exemplifies the creative and innovative spirit the award is intended to celebrate in clinical research professionals," said David M. Vulcano, immediate past chair of the ACRP Board of Trustees. "Those who earn this award have spearheaded projects that led to either time or cost savings, enabled better patient care and/or safety, and opened avenues for being reproduced by others in similar situations or circumstances."

About C-TASC Based near Baltimore, Clinical Trials & Surveys Corp. (C-TASC) is a clinical trials solutions company that has supported best practices management of clinical trials and studies for government, university and private organizations since 1989. C-TASC has a successful research history in cancer, cardiovascular disease, AIDS, pulmonary disease, Cystic Fibrosis, sleep disorders and pharmaco-epidemiology. C-TASC's software group utilizes the firm's StudyCTMSTM product suite to provide investigators with complete Web-based trial management designed to deliver FDA-acceptable data. The C-TASC professional services group provides expert consultation in all areas of clinical trial management including medical and statistical study design, project management, data conversion including FDA SDTM formatting, performance monitoring, data quality control and analysis as well as support for study publication and presentation. For more information about C-TASC's projects, products and services, please visit www.c-tasc.com<http://www.c-tasc.com/>.

Suggested Articles

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.

Johns Hopkins researchers developed a biodegradable polymer to transport large therapies into cells—including genes and even CRISPR.

UCB’s bispecific antibody recently beat Johnson & Johnson’s Stelara at clearing psoriasis symptoms, and now it has bested AbbVie’s Humira, too.